The company will survive and going forwards they will show the plan to make it a profitable venture. Right now they are clearing the decks and writing down assets that they will no longer concentrate on, look at the Biodel announcement and what they are doing there and then attribute the same across the PFS, Ocular, Novel and other devices they will no longer be concentrating on and potentially monetising so that they can concentrate soley on wearables!
Welcome to UNS, welcome to the never ending story!!
UNS Price at posting:
5.5¢ Sentiment: Hold Disclosure: Held